Marco Frontoni

Publications

Title	Published on	Year
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study	MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL	2022
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study	NEUROLOGICAL SCIENCES	2020
Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers	JOURNAL OF NEUROLOGY	2020
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients	SCIENTIFIC REPORTS	2019
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority	FRONTIERS IN NEUROLOGY	2019
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus	BIOMED RESEARCH INTERNATIONAL	2018
Photophobia in multiple sclerosis	MULTIPLE SCLEROSIS AND RELATED DISORDERS	2018
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis	NEUROLOGY	2016
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis	MULTIPLE SCLEROSIS	2016
Cost minimization analysis of BoNT-As in the treatment of upper limb spasticity and cervical dystonia	GLOBAL AND REGIONAL HEALTH TECHNOLOGY ASSESSMENT	2016